SCHEMBL7862846

SCHEMBL7862846

COCCNC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)cc2)cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
KMT2A Q03164 1/20 0.47
TSHR P16473 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
BLM P54132 2/20 0.45
CYP3A4 P08684 1/20 0.45
HTR1A P08908 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
NFKB1 P19838 1/20 0.45
CNR1 P21554 1/20 0.45
CYP2C19 P33261 1/20 0.45
ADRA1A P35348 1/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 1/20 0.44
THRB P10828 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867700 0.92 LMNA (0.45) LMNAKMT2ATSHRSMN1; SMN2BLM
SCHEMBL7867896 0.91 LMNA (0.49) LMNAKMT2ATSHRSMN1; SMN2BLM
SCHEMBL7862847 0.91 ALDH1A1 (0.47) KMT2ASMN1; SMN2HTTALDH1A1
SCHEMBL7867912 0.88 EGFR (0.47) KMT2ASMN1; SMN2ALDH1A1
SCHEMBL9018193 0.87 LMNA (0.53) LMNAKMT2ATSHRSMN1; SMN2BLM
SCHEMBL8869950 0.86 LMNA (0.54) LMNAKMT2ATSHRSMN1; SMN2BLM
SCHEMBL7869495 0.86 LMNA (0.45) LMNAKMT2ATSHRSMN1; SMN2HTT
SCHEMBL7871341 0.85 MAPT (0.46) LMNAKMT2ATSHRSMN1; SMN2BLM
SCHEMBL7871570 0.85 EGFR (0.45) KMT2ACA12CA9
SCHEMBL7867832 0.84 EPHX2 (0.43) LMNAKMT2ATSHRSMN1; SMN2BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed